Cita APA (7a ed.)
Ding, Y., Ding, K., He, X., Mo, W., Liang, C., Gong, L., . . . Ding, X. (2023, September 21). The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients. Clinical Medicine Insights: Oncology, 1-13.
Cita Chicago Style (17a ed.)
Ding, Yuqin, Kaijing Ding, Xiangming He, Wenju Mo, Chenlu Liang, Lijie Gong, Yuting Huang, y Xiaowen Ding. "The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients." Clinical Medicine Insights: Oncology 21 Sep. 2023: 1-13.
Cita MLA (9a ed.)
Ding, Yuqin, et al. "The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients." Clinical Medicine Insights: Oncology, 21 Sep. 2023, pp. 1-13.
Precaución: Estas citas no son 100% exactas.